At the beginning this summer UBICHEM Group, based in Budapest, Hungary, acquired a new manufacturing site. UBICHEM Pharma Manufacturing will be producing starting materials, intermediates and other fine chemical products for pharma and non-pharma applications in industrial quantities.
‘Feedback from our customers and partners made it obvious that there is a growing need for high quality and strict deadlines in the market for starting materials and intermediates,’ explained CEO József Répási. ‘We wanted to exploit our competitive advantage in these areas over Chinese and Indian manufacturers.’
The acquisition will support UBICHEM Group in enhancing its portfolio. From now on the company will be able to provide a comprehensive range of services from process r&d through pilot-scale cGMP API manufacture to high-volume manufacturing.
‘On the other hand we can use our resources more effectively, which means faster response times and competitive prices for our customers,’ added Répási. ‘In addition, by applying the rigorous quality control and strict production guidelines we have had in place at UBICHEM Pharma Services since 1996, we are able to ensure the high quality of the intermediates and fine chemical products at our new manufacturing site.’
SMEs are considered to be flexible, adaptive organisations, he believes, and they are able to compete with multinational companies because they provide flexible response to customer needs.
Hall 8 Stand C56
